Subscribe

AHC Group Inc. (7083.T)

JPY1,094.00 +99.00 (+9.95%)
JP JPX Healthcare Medical - Care Facilities
Address IT2 101-0032
Tokyo, JP
CEO Masahiro Morimoto
Website ahc.co.jp
IPO 2020-02-25
ISIN JP3160170001

Explore sections of this company profile

Description

AHC Group Inc., together with its subsidiaries, operates in the welfare, nursing care, restaurant, and other businesses in Japan. It offers welfare services, including after-school day and child development, employment transition, employment support, community living assistance, planning consultation and support, support for children with disabilities, and living support services; and operates Izakaya restaurants. In addition, the company is involved in processing and selling food products; providing operational guidance and nursing care; welfare and restaurant businesses; temporary worker dispatch; AI-assisted record-keeping app business; DX support services for businesses; and paid employment job placement services, as well as operates in the back-office service and real estate businesses. AHC Group Inc. was incorporated in 2010 and is headquartered in Tokyo, Japan.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
JPY1,094.00 +99.00 (+9.95%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
5.6K
Beta
-0.17
Float Shares
626.9K
Free Float %
30.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-0.52% -1.54% +7.43% -7.15% -12.56% -12.95% -22.63% +20.63% -41.12% -78.18% -78.18%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
1,094.00
DCF (Levered) 1,079.87 -1.3%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2024-11 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.89
Grey zone
Piotroski F-Score
3 / 9
Average
MOAT Score
2 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Care Facilities: +10.2%
    +6.1% Q2'26: +5.7% (vs Q2'25)
  • EPS growth Medical - Care Facilities: +19.2%
    -99.0% Q2'26: +57.9% (vs Q2'25)
  • FCF margin FCF growth · Medical - Care Facilities: +32.0%
    -0.1% Q2'26: +0.0% (vs Q2'25)
  • EBIT margin Medical - Care Facilities: +11.3%
    +1.5% Q2'26: +2.0% (vs Q2'25)
  • ROIC Medical - Care Facilities: +6.8%
    +2.0% Q2'26: +2.7% (vs Q2'25)
  • Share dilution Medical - Care Facilities: +0.0%
    -0.8% Q2'26: -1.2% (vs Q2'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    15.41× Q2'26: 14.32× (vs Q2'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (-0.19) × ERP
WACC = 28% × Ke + 72% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Current price: 1,094.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Nov 2020
actual
Nov 2021
actual
Nov 2022
actual
Nov 2023
actual
Nov 2024
actual
Nov 2025
actual
Nov 2026
1 Rev. Ana.
1 EPS Ana.
Revenue
4.09B
est: 4.65B (-12.0%)
4.11B
est: 4.58B (-10.2%)
4.90B
est: 5.35B (-8.2%)
5.92B
est: 6.18B (-4.2%)
6.28B
est: 6.34B (-1.0%)
6.66B
est: 6.77B (-1.6%)
7.29B
7.29B – 7.29B
+7.6% YoY
EBITDA
177.45M
est: 152.61M (+16.3%)
157.48M
est: 150.60M (+4.6%)
-123.99M
est: 175.60M (-170.6%)
241.43M
est: 202.94M (+19.0%)
313.77M
est: 473.53M (-33.7%)
256.37M
est: 505.56M (-49.3%)
544.01M
544.01M – 544.01M
+7.6% YoY
EBIT
106.82M
est: 55.93M (+91.0%)
74.07M
est: 55.19M (+34.2%)
-231.76M
est: 64.36M (-460.1%)
86.76M
est: 74.37M (+16.6%)
163.18M
est: 269.22M (-39.4%)
83.69M
est: 287.43M (-70.9%)
309.30M
309.30M – 309.30M
+7.6% YoY
Net Income
102.76M
est: 227.91M (-54.9%)
1.31M
est: 94.87M (-98.6%)
-253.89M
est: 1.08M (-23,649.8%)
67.87M
est: 8.19M (+728.3%)
98.32M
est: 74.46M (+32.0%)
1.02M
est: 137.59M (-99.3%)
202.85M
202.85M – 202.85M
+47.4% YoY
SGA
357.56M
est: 417.84M (-14.4%)
397.82M
est: 412.35M (-3.5%)
462.97M
est: 480.81M (-3.7%)
493.14M
est: 555.65M (-11.3%)
554.23M
est: 574.18M (-3.5%)
598.95M
est: 613.02M (-2.3%)
659.64M
659.64M – 659.64M
+7.6% YoY
EPS
49.16
est: 105.70 (-53.5%)
0.63
est: 44.00 (-98.6%)
-121.82
est: 0.50 (-24,464.0%)
32.35
est: 3.80 (+751.3%)
47.01
est: 34.80 (+35.1%)
0.49
est: 64.30 (-99.2%)
94.80
94.80 – 94.80
+47.4% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-28 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-27 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-26 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-25 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-22 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-21 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-20 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-19 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-18 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-15 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-14 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-13 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-05-12 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-05-11 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-05-08 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-05-07 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-05-01 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-30 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-28 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-27 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-24 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-23 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-22 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-21 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-20 C+ 2/5 5/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 B 3/5 5/5 2/5 4/5 1/5 1/5 4/5
2026-04-16 B 3/5 5/5 2/5 4/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
102.76M
OE per share TTM
48.35
Owner's Yield
6.50%
Maintenance CapEx ratio
106.24%
Maint CapEx / Avg PPE
19.3%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock

This company is not held by any ETF in our universe.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
168.7K
Shares Outstanding
2.06M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Kojiro Yoshimoto Director of Nursing Care & West Japan Welfare Division and Director male
Shigeta Tsuchiyama Executive Vice President & Director male
Terukazu Muto GM of Business Management Headquarters & Director male
Tomonori Hamada Head of East Japan Welfare Division & Director male
Yoshitaka Araki Chief Executive Officer, President & Representative Director male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits